Overview

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Status:
Completed
Trial end date:
2008-08-12
Target enrollment:
Participant gender:
Summary
A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Valacyclovir